Biogen Inc. buy Truist Financial Co.
Start price
25.03.24
/
50%
€199.50
Target price
25.03.25
€313.72
Performance (%)
-2.11%
Price
26.04.24
€195.30
Summary
This prediction is currently active. With a performance of -2.11%, the BUY prediction by Truist_Financial_Co_ is trending in the wrong direction. This prediction currently runs until 25.03.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | 7.014% | 7.014% |
| iShares Core DAX® | 2.594% | -1.158% |
| iShares Nasdaq 100 | 3.553% | -1.727% |
| iShares Nikkei 225® | 0.687% | -8.354% |
| iShares S&P 500 | 2.209% | -0.942% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $340.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat